CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[China Eastern Airlines Corporation Limited Date By Wang Jian Company Secretary 2 List of Directors and their Role and Function Board The members of the board of directors (the ]
MPEL [Melco Resorts & Entertainment] 6-K: (Original Filing)
[This announcement appears for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities. Melco International Development Limited (Incorporated in Hong Kong with limited liability) Website : www.melco-group.com (Stock Code : 200) CONNECT]
SORL [SORL Auto Parts] 8-K: (Original Filing)
[SORL Auto Parts Reports Record Annual Net Sales ZHEJIANG, China, April 2, 2018 -- SORL Auto Parts, Inc. (NASDAQ: SORL) Fourth Quarter 2017 Financial Highlights · Net sales for the 2017 fourth quarter rose 43.4% to $123.0 million from $85.5 million in the 2016 fourth quarter; · Revenues from the dome]
PTR [PETROCHINA CO] 6-K: (Original Filing)
[中國石油天然氣股份有限公司 PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 857) Resignation of Director and President Board Company The board of directors (the Mr. Wang Dongjin has confirmed that he has no disagreemen]
FENG [Phoenix New Media] 6-K: (Original Filing)
[Phoenix New Media Announces Yidians Financing Update BEIJING, April 3 , 2018 - Phoenix New Media Limited (Phoenix New Media, ifeng or the Company) (NYSE: FENG), a leading new media company in China, today announced certain financing update of Particle Inc. (Particle). Particle owns Yidian Z]
BSPM [Biostar Pharmaceuticals] NT 10-K: (Original Filing)
[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 ☒ ☐ ☐ (Check One): ☐ ☐ ☐ For Period Ended: December 31, 2017 ☐ ☐ ☐ ☐ ☐ For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained he]
CPHI [CHINA PHARMA] 10-K: (Original Filing)
[] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD84,849.59 respectively as of December 31, 2017. Due to the fact the Company temporarily did]
